Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics-Reference-Cited by-同舟云学术

Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics

Published:2018 Issue:1 Volume:59 Page:87-93
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Nakamura Makiko¹,Sunagawa Osahiko²,Kinugawa Koichiro¹

Affiliation:

1. Second Department of Internal Medicine, University of Toyama

2. Department of Cardiology, Okinawa Prefectural Nanbu Medical Center and Children's Medical Center

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/59/1/59_17-099/_pdf

Reference24 articles.

1. 1. Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007; 297: 1319-31.

2. 2. Imamura T, Kinugawa K, Shiga T, et al. Novel criteria of urine osmolality effectively predict response to tolvaptan in decompensated heart failure patients--association between non-responders and chronic kidney disease. Circ J 2013; 77: 397-404.

3. 3. Imamura T, Kinugawa K, Minatsuki S, et al. Tolvaptan can improve clinical course in responders validation analysis for the definition of responsiveness by urine volume. Int Heart J 2013; 54: 377-81.

4. 4. Felker GM, Lee KL, Bull DA, et al. diuretic strategies in patients with acute decompensated heart failure. N Eng J Med 2011; 364: 797-805.

5. 5. Felker GM, O'Connor CM, Braunwald E; Heart Failure Clinical Research Network Investigators. Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ Heart Fail 2009; 2: 56-62.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Potential Therapeutic Targets in Autosomal Dominant Polycystic Kidney Disease from the Perspective of Cell Polarity and Fibrosis;Biomolecules & Therapeutics;2024-04-09

2. Effectiveness of urea administration for the treatment of hyponatremia in heart failure;Medicina Clínica (English Edition);2024-01

3. Efectividad de la administración de urea para el tratamiento de la hiponatremia en la insuficiencia cardiaca;Medicina Clínica;2024-01

4. Association between hyponatremia and adverse clinical outcomes of heart failure: current evidence based on a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2023-12-22

5. Early Commencement and Long-Term Continuation of Tolvaptan Treatment Attenuate Functional Impairment of Renal Vasopressin V2 Receptors and Improve Clinical Outcomes in Patients with Heart Failure;International Heart Journal;2023-03-31